Emily Freeman PhD

Dr. Emily Freeman is a social/behavioral scientist interested in the knowledge translation of medical evidence from clinical trials to evidence-based communication tools for patients and HCP's.

She is exploring how medical evidence (i.e. risk, benefit, and health outcomes) is constructed and communicated within a patient-healthcare provider clinical encounter. In addition she is interested in the intersection of medical evidence and patient's preferences and the impact on shared treatment decisions. Emily’s research has focused on the impact of shared treatment decision making on the quality of care received by patients and using shared decision making as a tool for patient engagement. Finally, she is interested in bringing a more patient-centered approach to drug development through patient-reported and defined outcomes.